Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation

A Functionally Significant Cross-talk between Androgen Receptor and ErbB2 Pathways in Estrogen Receptor Negative Breast Cancer

(2015) Ali Naderi et al.   NEOPLASIA

Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast Cancer

(2009) A. M. Gonzalez-Angulo et al.   CLINICAL CANCER RESEARCH

Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

(2009) Judith Hugh et al.   JOURNAL OF CLINICAL ONCOLOGY

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

(2009) Joel S. Parker et al.   JOURNAL OF CLINICAL ONCOLOGY

Estrogen and Progesterone Receptors in Breast Carcinoma: Quantitation is Therapeutically Important

(2008) Rohit Bhargava et al.   ADVANCES IN ANATOMIC PATHOLOGY

Androgen receptor expresion in breast cancer: Relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors

(2008) Luis O Gonzalez et al.   BMC CANCER

Therapeutic Strategies for Triple-Negative Breast Cancer

(2008) Antoinette R. Tan et al.   CANCER JOURNAL

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

(2008) M. C.U. Cheang et al.   CLINICAL CANCER RESEARCH

Aromatase in Human Breast Carcinoma as a Key Regulator of Intratumoral Sex Steroid Concentrations

(2008) Takashi SUZUKI et al.   ENDOCRINE JOURNAL

Androgen receptors as a prognostic and predictive factor in breast cancer.

(2008) Anil K Agrawal et al.   FOLIA HISTOCHEMICA ET CYTOBIOLOGICA

Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory

(2008) Zeina Nahleh   Future Oncology

Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers

(2008) Yoshinari Ogawa et al.   International Journal of Clinical Oncology

Histopathologic variables predict Oncotype DX™ Recurrence Score

(2008) Melina B Flanagan et al.   MODERN PATHOLOGY

Minireview: Nuclear Receptors and Breast Cancer

(2008) Suzanne D. Conzen   MOLECULAR ENDOCRINOLOGY

The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2

(2008) Aleix Prat et al.   Nature clinical practice. Oncology